Invention Grant
- Patent Title: Use of parvovirus for eliminating cancer stem cells (CSCs)
-
Application No.: US15617265Application Date: 2017-06-08
-
Publication No.: US10525091B2Publication Date: 2020-01-07
- Inventor: Jean Rommelaere , Jeannine Lacroix , Joerg Schlehofer , Olaf Witt , Elisabeth Hedwig Deubzer , Sonja Kern , Christel Herold-Mende , Karsten Geletneky , Barbara Leuchs
- Applicant: Deutsches Krebsforschungszentrum , Ruprecht-Karls-Universitaet Heidelberg
- Applicant Address: DE Heidelberg DE Heidelberg
- Assignee: DEUTSCHES KREBSFORSCHUNGSZENTRUM,RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG
- Current Assignee: DEUTSCHES KREBSFORSCHUNGSZENTRUM,RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG
- Current Assignee Address: DE Heidelberg DE Heidelberg
- Agency: Hultquist, PLLC
- Agent Steven J. Hultquist
- Priority: EP10007007 20100707
- Main IPC: A61K39/23
- IPC: A61K39/23 ; A61K35/768
Abstract:
Described is the use of a parvovirus, preferably H-1PV, for the therapeutical elimination of cancer stem cells (CSCs), preferably neuroblastoma stem cells and glioblastoma stem cells.
Public/Granted literature
- US20170266244A1 USE OF PARVOVIRUS FOR ELIMINATING CANCER STEM CELLS (CSCs) Public/Granted day:2017-09-21
Information query
